European Medicines Agency changes policy on clinical trial data publication

BMJ 2014; 348 doi: (Published 17 June 2014) Cite this as: BMJ 2014;348:g4073
  1. Rory Watson
  1. 1Brussels

The London based European Medicines Agency (EMA) is changing its data sharing policy after criticism from the European ombudsman Emily O’Reilly, Labour MEP Glenis Willmott, the AllTrials campaign, and researchers, patients, and the public.

At its management board meeting on 12 June, the agency agreed to a proposal from executive director Guido Rasi to remove the access restriction in its data sharing policy from on screen only to allow researchers to download, save, and print clinical study reports for academic and non-commercial research purposes.

In addition, the board agreed to allow the agency …

View Full Text

Log in

Log in through your institution


* For online subscription